Clinical Trials
Ferrer announces first patient enrollment of FNP122 in ADORE Phase III clinical trial for Amyotrophic Lateral Sclerosis treatment
Ferrer, an international pharmaceutical company focused on neurological disorders and pulmonary vascular and interstitial lung diseases, has announced the next major milestone in its...
News
CorporateServe Strengthens Its Commitment Towards Pharma With PharmaSoft 2.0
CorporateServe, the country’s leading provider of Enterprise Resource Planning and Business Intelligence solutions across industries strengthen its commitment towards the healthcare & pharma industry...
News
Pharma confidence surges as CPhI Worldwide 2021 opens
CPhI Worldwide – hosted in-person at Fiera Milano, Italy (9-11 November, 2021) – opens its doors to international pharma for the first time in...
Articles
Samsung Biologics – how are CDMOs affected post Covid commentary
Impact of COVID-19 on Biopharma CDMO Market: Innovation and Investment
The COVID-19 pandemic has strained resources across the globe and impacted nearly every sector. Arguably,...
Articles
AES Clean Technology Post-COVID Supply Chain Commentary
OCT 2021 At AES Clean Technology, we had front-row seats to many of the challenges and triumphs created by the pandemic. There were several...
Articles
INCOG: Supply chain commentary
Tedd Green, COO at INCOG Biopharma Services discusses the supply chain challenges that pharmaceutical companies have faced due to the COVID-19 pandemic and what...
Articles
ChargePoint Technology: Post-COVID Supply Chain Commentary
The pharmaceutical industry and its supply chain have both undergone considerable upheaval due to the COVID-19 pandemic. The closure of factories in Asia producing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read